ABSTRACT
The past decade has seen widespread advances in quality control (QC) materials and software tools focused specifically on mass spectrometry–based proteomics, yet the rate of adoption is inconsistent. Despite the fundamental importance of QC, it typically falls behind learning new techniques, instruments, or software. Considering how important QC is in a core setting where data is generated for non–mass spectrometry experts and confidence in delivered results is paramount, we have created this quick-start guide focusing on off-the-shelf QC materials and relatively easy-to-use QC software. We hope that by providing a background on the different levels of QC, different materials and their uses, describing QC design options, and highlighting some current QC software, implementing QC in a core setting will be easier than ever. There continues to be development in each of these areas (such as new materials and software), and the current generation of QC for mass spectrometry–based proteomics is more than capable of conveying confidence in results as well as minimizing laboratory downtime by guiding experimental, technical, and analytical troubleshooting from sample to results.
Keywords: quality control, proteomics, software, materials, standards, best practices
INTRODUCTION
Ensuring the validity of results is important in all areas of science but is especially important to research cores generating and providing data and results to other scientists who must be confident in the measurements before drawing meaningful biological conclusions. Broadly, this is accomplished by using a quality system encompassing everything from the calibration of pipettes to validating methods for checking instrument performance to inspecting the final results. Quality control (QC) is a subset of quality systems, which for mass spectrometry cores includes everything from sample preparation to data acquisition and initial analysis. It is useful, arguably essential, to isolate and evaluate instrument performance before, during, and after a series of sample measurements (known as a run), independently of the experimental samples.1,2,3 Isolating instrument performance from experimental processes is often referred to as system suitability testing (SST). On the other hand, QC materials of varying complexity and relevance can be processed and run parallel to experimental samples to provide confidence in the total workflow from samples to results. Providing SST and QC performance to clients or users along with experimental results is essential, especially when results are negative or perceived as suboptimal. The goal of this review is to provide a “starter kit” of off-the-shelf materials, QC approaches, and QC software for any mass spectrometry proteomics core or research group to implement QC (skip to the Recommendations section) as well as to provide a reference to more in-depth QC concepts if needed, but not required.
Most mass spectrometry–based proteomics cores routinely run QC materials to ensure reliable and informative results. Such QC samples are used to verify instrument performance, validate and benchmark methods within and across laboratories, and even comply with regulatory standards.4,5 Especially in multi-laboratory consortia, large sample sets, or long-term data collection, QC is imperative to combine data across instruments, laboratories, and time.6 Critically, QC samples allow separation of extrinsic measurement variance from intrinsic sample variability—something which is especially pertinent to laboratories serving a diverse group of users with varying experience levels. Historically, many mass spectrometry proteomics laboratories have manufactured their own QC samples, for example, by mixing selected compounds or digesting proteins from Escherichia coli or yeast whole-cell lysates. A number of mixtures suitable for QC purposes are now commercially available, including several developed in collaboration with Association of Biomolecular Resource Facilities (ABRF) research groups,7,8 aiding in reproducibility, comparability, and harmonization across experiments, instruments, laboratories, and time.
Common QC materials and analysis methods (including data processing) must be used so that data can be comparable across laboratories. We will focus on these QC standards and QC methods, with “standard” understood in the general sense rather than in the stricter definition from analytical chemistry implying certified mass fractions of a specific substance or substances that are absolutely quantified. There are QC materials used in proteomics with known mass fractions that can be used to evaluate quantitative accuracy and detection limits, but in general, these materials are comparative in nature. In an effort to simplify the discussion herein, the following designations will be used, modified from Bittremieux et al.3 (Figure 1):
Figure 1. Four Levels of QC Material. In general, there are 4 types, or levels, of QC materials, described in the Introduction section and in detail throughout. A QC1 material is a mixture of peptides (shown in cyan and red), isotopically labeled or not; a QC2 material is a whole-cell digest or biofluid digest (shown as a green lined “cell” with its components); and a QC3 material is a mix of isotopically labeled peptides mixed into a more complex whole-cell digestor biofluid. Finally, a QC4 material is 2 or more samples of whole-cell lysate or biofluid digests (here, A and B) that have known mixtures of different species’ proteomes (shown as green versus pink cells, at ratios of 2:1 or 1:2). Note that this is only describing types of QC materials, while recommendations for implementing QC in experimental design can be found in the Methods for Implementing QC section.

QC1: A known mixture of peptides or a digest of a single protein or set of proteins, typically used for SST or spiking into experimental or QC samples.
QC2: A whole-cell lysate or biofluid processed along with the experiment (used as a process QC) or a digest of a whole-cell lysate to be used for SST.
QC3: A spike of isotopically labeled peptides (like a QC1) into a complex whole-cell lysate or biofluid digest (like a QC2) to be used for SST.
QC4: A suite of 2 or more samples of whole-cell lysates or biofluids used within the experiment (as a QC) or predigested (SST) to quantify label-free or isotopically labeled quantification accuracy and precision. Each sample could contain different species mixtures, or be a biofluid, cell type, or environmental sample with known or predicted proteome-wide differences. This suite could likewise contain isotopically labeled peptides (QC1), similar to the construction of QC3. A variation of QC4 would be a suite of premixed isobarically labeled samples.
These definitions reflect the types of material and their use cases, determining what QC information they can provide. A QC1 sample can be run on a short gradient independently of an experiment, can be designed to be shelf stable, and is relatively inexpensive. A QC2 sample would typically be analyzed with the same gradient length as the experimental samples and therefore be slightly more expensive in terms of instrument time but is excellent at checking experimental and instrument performance. Likewise, a QC3 sample can provide the same information as QC2 samples with the addition of quantitative detection limits of the method and/or retention time calibration and will be used nearly as frequently as QC2 in most laboratories. In contrast, QC4 requires multiple injections and therefore more instrument time and may not be run as regularly as QC1, QC2, or QC3 in most cores, despite potentially providing valuable insight into method accuracy and precision. The frequency of using a type of QC will vary between cores, depending on the types and scale of experiments that are analyzed. For instance, a core providing quantitative proteomics measurements requires higher levels of QC than a core that only provides protein identifications. A core performing metaproteomics analyses has more need for mixed proteome materials than a core that only analyzes human samples.
QC APPROACHES AND METHODS
How QC materials are used in a mass spectrometry proteomics core largely depends on the client/user needs and experimental designs. In a very basic sense, SST should be universal. All mass spectrometers need to be periodically calibrated, as mass measurements are affected by changes in the environment, notably temperature, in electronic components, in detectors, and in ion optics, especially as contamination builds up on internal components. System suitability testing is performed prior to the analysis of samples to confirm that the instrument is performing within instrument and experiment-specific operational margins, a concept formally known as statistical process control.5 This concept relies on longitudinal QC measurements to establish the acceptable (inherent) variation of a system in order to detect unexpected deviations from this baseline that must be addressed before continuing. Normally, SSTs should encompass as much of the data acquisition path as possible. Since most mass spectrometry–based proteomics methods utilize liquid chromatography (LC), the SST should include the LC and not simply rely on a direct infusion of QC material onto the instrument. Likewise, the SST should be reasonably complex; otherwise, it may not identify unexpected deviations. For instance, modern instruments may still detect some QC1 within acceptable margins even when performing poorly, and therefore, some QC1 may not be fit for SST. Once the system is confirmed to be performing properly, the analysis of experimental samples can proceed with confidence.
Many software utilize retention time calibration to improve database searching and identification, and these retention time standards can also be used for QC.9,10 Retention time calibration standards11 are typically added to each individual sample in LC–tandem mass spectrometry (LC-MS/MS) in order to align chromatograms12 or normalize retention times.13 These standards can also function as QC1 mixtures and be used for some QC tasks. Mass spectrometry calibration standards are less suited, however, as they are typically injected directly into the mass spectrometer. Conversely, both retention times14 and mass spectra15 can be aligned (retention time) or calibrated (m/z) without standards, using identified peptides that reveal drifts in either retention time or mass measurement. Typically, LC-MS/MS datasets are aligned in order to assist peak integration across runs and transfer identifications between the runs,14 a practice also known as “match between runs.”16 Normalizing or calibrating retention times takes this one step further and expresses retention times as a normalized elution time relative to the elution profiles of tryptic peptides, or estimates the fraction of organic solvent (e.g., acetonitrile) at elution, as recently demonstrated by Bouwmeester et al. 17 Knowledge of downstream analysis capabilities and whether a specific QC1 is required is essential to taking advantage of these techniques in the core.
Many QC materials can be used as ground truth for benchmarking both data acquisition and data analysis methods and parameters with respect to peptide and protein identification or quantification. For instance, a known spiked-in peptide or protein, or whole proteomes mixed in known ratios, can be used to specifically evaluate if the acquired and analyzed data reflects the true changes in relative abundance in the sample. Data from some QC standards are also available in ProteomeXchange (Table 1).18 This data can be used to QC and benchmark data analysis methods, determining whether an issue is due to the measurement or the data analysis. This can be especially useful since different peptide identification approaches affect protein quantification in quantitative proteomics experiments.19 For instance, in metaproteomics, a large search space can drastically affect identification depth and biological conclusions.20,21 Using external datasets provides independent confidence of chosen data analysis workflows.
Commercially Available QC Materials.
|
Note that this list is not exhaustive and is specific to LC/MS-based proteomics (as opposed to MALDI or other mass spectrometric techniques). The “public dataset” column refers to ProteomeXchange, if available. “Labeled” refers to isotopically (including isobarically) labeled. | |||||||
|
Type |
Material Name |
QC level(s) |
Labeled |
Supplier |
Product no. |
Description/application |
Public datasets |
|---|---|---|---|---|---|---|---|
|
peptides |
Pierce Peptide Retention Time Calibration (PRTC) Mixture |
QC1 |
yes |
Thermo Fisher Scientific |
88321 |
15 labeled peptides RT calibration |
PXD034525 PXD016573 PXD001731 |
|
peptides |
MS RT Calibration Mix |
QC1 |
no |
Sigma |
MSRT1 |
14 peptides for RT cal |
PXD008983 PXD004712 |
|
peptides |
MS Qual/Quant QC Mix |
QC1 |
both |
Sigma |
MSQC1 |
6 protein digest spiked with labeled peptides (2 to 3 per protein); LC-MS/MS SST, quant, LOD determination |
MSV000089339 |
|
peptides |
iRT kit |
QC1 |
no |
Biognosys |
11 peptides for RT cal and QC |
PXD015026 PXD043613 PXD017217 |
|
|
peptides |
6 x 5 LC-MS/MS Peptide Reference Mix 52 |
QC1 |
yes |
Promega |
V749A |
6 sets of 5 isotopologues; RT calibration, LC-MS/MS SST, quant, LOD determination |
|
|
peptides |
Pierce 6 Protein Digest, equimolar, LC-MS grade |
QC1 |
no |
Thermo |
88342 |
Digest of 6 proteins at equimolar levels |
|
|
peptides |
Pierce LC-MS/MS System Suitability Standard (7 x 5 mixture) |
QC1 |
yes |
Thermo Fisher Scientific |
A40010 |
7 sets of 5 isotopologues; RT calibration, LC-MS/MS SST, quant, LOD determination |
|
|
peptides |
HSA Peptide Standard Mix Kit |
QC1 |
no |
Agilent |
G2455-85001 |
Human serum albumin peptides |
PASSEL (PASS01166) |
|
peptides |
10-peptide standard |
QC1 |
no |
Agilent |
5190-0583 |
||
|
peptides |
MS PhosphoMix 1, 2, and 3 (light and heavy) |
QC1 |
yes |
Sigma |
MSP1L MSP1H MSP2L MSP2H MSP3L MSP3H |
All 3 mixes contain peptides of the same sequences with different sites of phosphorylatio n |
PXD025754 |
|
peptides |
SureQuant Phosphopeptid e Suitability Standards |
QC1 |
yes |
Thermo |
A51745 |
131 isotopically labeled phosphopeptid es |
MSV0000905 64 |
|
peptides |
SureQuant AKT Pathway (Phospho) Multiplex Panel (Absolute Quantitation) |
QC1 |
yes |
Thermo |
A40084 |
30 unique peptides from 10 AKT-mTOR signaling pathway target proteins |
|
|
peptides |
SureQuant AKT Pathway Multiplex Panel (Relative Quantitation) |
QC1 |
yes |
Thermo |
A40080 |
30 unique peptides from 10 AKT-mTOR signaling pathway target proteins |
PXD019426 |
|
peptides |
Waters MassPREP Digestion Standard Mix 1 and Mix 2 |
QC1 |
no |
Waters |
186002865 186002866 |
Tryptic digest of 4 proteins mixed at known levels |
PXD040205 |
|
peptides |
Retention Time Standardization Kit (PROCAL) |
QC1 |
no |
JPT |
RTK-1-10pmol |
Pool of 40 non-naturally occurring endecamers for RT normalization |
PXD006832 |
|
peptides |
JPT’s SpikeMix ABRF (cross-species standard) |
QC1 |
yes |
JPT |
SPT-ABRF-POOL-L-1pm |
1,000 heavy labeled proteotypic peptides for proteins conserved between rat, mouse, and human |
PXD017385 |
|
peptides/protein |
MS QCAL Peptide Mix 35 |
QC1/QC2 |
QconCAT derived 22 peptides |
Sigma, PolyQuant |
MSQC2 (Sigma) PQ-CS-5370 PQ-CS-5371 (PolyQuant) |
QconCAT derived 22 peptides (digested or undigested); RT monitoring, LOD |
PXD023654 |
|
peptides/protein |
RePLiCal |
QC1 |
yes |
Polyquant |
PQ-CS-1560, PQ-CS-1561, PQ-CS-2560, PQ-CS-2561 |
27 lysineterminating calibrant peptides from a QconCAT construct. The peptides do not contain any M, W, C, or N-terminal Q. |
PXD017029 PXD012317 |
|
peptides |
Mass Spec-Compatible Yeast and Human Protein Extracts |
QC2 |
no |
Promega |
V7461 V6951 |
Yeast or Human K562 digests; SST |
|
|
peptides |
MassPREP E. coli Digest Standard |
QC2 |
no |
Waters |
186003196 |
E. coli digest for SST or inrun QC |
|
|
peptides |
Pierce HeLa Protein Digest Standard |
QC2 |
no |
Thermo |
88328 |
HeLa digest for SST or inrun QC |
|
|
peptides |
Pierce HeLa Digest/PRTC Standard |
QC3 |
both |
Thermo |
A47997 |
HeLa digest + PRTC peptides for SST or inrun QC |
PXD031426 |
|
peptides |
Pierce TMT11plex Yeast Digest Standard |
QC2/QC3/QC4 |
yes |
Thermo |
A40939 |
TMT-labeled yeast digest for SST or inrun QC |
|
|
peptides |
Pierce Yeast Digest Standard |
QC2 |
no |
Thermo |
A47951 |
Yeast digest for SST or inrun QC |
|
|
peptides |
NIST RM 8321—Peptide Mixture for Proteomics |
QC1 |
no |
NIST |
RM 8321 |
Endogenous human peptide mixture |
|
|
protein |
NIST RM 8671—NISTmAb, Humanized IgG1K Monoclonal Antibody |
QC2 |
no |
NIST |
RM 8671 |
mAb |
|
|
protein |
SILuMAB Stable Isotope Labeled U niversal Monoclonal Antibody Standard human |
QC2 |
yes |
Sigma |
MSQC3 |
Internal standard for universal MAB sequences |
|
|
protein |
NIST SRM 2926/2927—Recombinant Human Insulin-like Growth Factor 1 (15N-Labeled or not) |
QC2 |
no/yes |
NIST |
SRM 2926 SRM 2927 |
||
|
protein mix |
Protein Mass Spectrometry Calibration Standard (UPS1) |
QC2 |
no |
Sigma |
UPS1-1KT |
5 moles each of 48 human proteins |
PXD001819 PXD002370 |
|
protein mix |
Proteomics Dynamic Range Standard Set (UPS2) |
QC2 |
no |
Sigma-Aldrich |
UPS2-1SET |
6 mixtures of 8 proteins, each ranging from 50 pmol to 500 amol; LC-MS/MS SST, LFQ (iBAQ) |
PXD000331 |
|
protein mix |
Universal Proteomics Standard 3 (UPS3) |
QC2 |
no |
Sigma-Aldrich |
UPS3-1VL |
8 nonhuman proteins, 100 to 0.1 pmol |
PXD007039 |
|
protein mix |
Pierce Intact Protein Standard Mix |
QC2 |
no |
Thermo |
|||
|
protein mix |
Protein Standard Mix 15 to 600 kDa |
QC2 |
no |
Supelco |
69385 |
5 SEC markers |
|
|
cells/lysate |
Mass Spec-Compatible Yeast and Human Protein Extracts |
QC2 |
no |
Promega |
V7341 V6941 |
Yeast or Human K562 “intact extract” |
|
|
cells/lysate |
NIST RM 8461—Human Liver for Proteomics |
QC2 |
no |
NIST |
RM 8461 |
Stable freeze-dried powder, digestion method check |
PXD009021 PXD013608 |
|
cells/lysate |
NIST RM 8323—Yeast Protein Extract |
QC2 |
no |
NIST |
RM 8323 |
Yeast extract |
described in ref. 45 |
|
cells/lysate |
NIST RGTM 10197—NISTCHO Test Material, Clonal CHOK1 Cell Line Producing NISTmAb |
QC2 |
no |
NIST |
RGTM 10197 |
CHO line expressing NIST mAb (see NIST RM 8671). This has not been demonstrated fit for purpose for proteomics, but NIST mAb has been extensively characterized. |
|
|
Cells/lysate |
ZymoBIOMICS Microbial Community Standards |
QC2 |
no |
Zymo |
D6300 D6310 D6320 D6321 D6323 D6331 |
Whole-cell mock communities, mixes, or materials |
PXD015500 |
|
cells/lysate |
ATCC whole-cell mixes |
QC2 |
no |
ATCC |
MSA-2002 MSA-2003 MSA-2004 MSA-2005 MSA-2006 MSA-2007 MSA-2008 MSA-2010 MSA-2014 |
Whole-cell mock bacterial and virus communities, mixes, or materials |
|
| |||||||
The different methods utilizing QC materials described above are vital when embarking on mass spectrometrybased proteomic analysis of hundreds or thousands of samples. Different QC level samples should be distributed throughout the run to provide near real-time evaluation of experimental issues and instrument performance, including changes in chromatographic separation, mass measurement accuracy and measurement sensitivity, and actionable go/no-go metric for the next sample injection. Here, QC2 materials run in parallel with the samples can be used to evaluate upstream preparation steps, for example, homogenization, enzymatic digestion, and clean-up errors, which are the primary source of technical variability in a proteomics workflow, 22 while QC3 samples serve as in-run SSTs, as they provide information on linearity and limit of quantitation. Any changes beyond acceptable margins can indicate the sequence of analyses should be interrupted and problems addressed before continuing. The troubleshooting can itself be aided by the full range of QC materials. Even when measurements are running smoothly, the QC materials aid in quantifying experimental and technical variability and provide essential assurance to end-users seeking biological insights.
Lastly, it is important to note that QC samples can be used regardless of experimental design, but certain approaches require specific materials to provide desired quality metrics (discussed in detail in the QC Metrics section below). Historically, most QC metrics in proteomics, such as the numbers of peptide spectrum matches or identified proteins, have been based on bottom-up, data-dependent acquisition (DDA) and label-free analysis. However, in data-independent acquisition (DIA) and isotopically labeled experiments, modified or additional quality metrics are useful. In the future, DIA performance metrics may borrow more from DDA-centric metrics. One possibility might be that similar to how peptide spectral match identification rate can be reported from DDA data, in DIA data it may instead be the average number of peptides identified per DIA MS2 window per retention time window (since each window is deliberately chimeric and can yield multiple peptide matches).23 Moreover, as multiple spectra are often used for quantitation in DIA, the number of data points per chromatographic peak is informative on the quality of the quantitative data. For some isobaric labeling methods, generating reporter ions at low m/z, such as iTRAQ24 or tandem mass tags (TMT),25 the resolving power and background in the reporter ion m/z region is particularly important for quantitative accuracy, whereas such measures have little relevance in label-free experiments. Though not discussed here, mass spectrometry-based metabolomics and lipidomics have many similarities in methods and approaches,26, 27 albeit using different materials. Likewise, spatial methods such as MALDI28 and DESI29 mass spectrometry imaging require spatially informative QC samples and metrics,30 but these deserve special consideration and are outside the scope of this primer. Finally, when working in an unfamiliar tissue or species, QC materials become even more valuable, since otherwise poor performance could be chalked up to data being the “first of its kind” or due to the FASTA used in searching, when in reality it could be underlying methodological or technical issues. Although using a tissue- and species-specific QC2 level material is optimal, this may not be possible, and in these cases, some sort of QC material should still be used regardless. Since some QC materials and metrics can be specific to the type of mass spectrometry analysis or experimental question, it is recommended that a QC plan be developed for each service that a mass spectrometry core offers. Specifically, this QC plan should define what QC materials and methods will be used and what information will be communicated to clients/users along with their results as well as a priori-defined threshold values that would lead to a reanalysis. Overall, there are many approaches to implementing QC, but we encourage cores to adopt some QC, since any QC is better than no QC.
QC MATERIALS
Two decades ago, there were no commercially available QC materials bespoke for LC-MS/MS-based proteomics, though QC1 single-protein (e.g., bovine serum albumin) tryptic digests were commonly used. In part to address this lacuna, the Proteomics Standards Research Group (sPRG) of the ABRF developed 2 multiprotein standard mixtures, UPS1 and UPS2, in collaboration with Sigma-Aldrich in 2006.31 These standards are still commercially available in 2023. The sPRG has also developed a multispecies material that is available through JPT Peptide Technologies,7 a phosphoproteomics standard that is commercialized by Thermo Fisher Scientific,8 and a multispecies whole proteome mixture currently in development. These and other QC materials have different applications that in principle can be combined to provide a richer quality evaluation. Though laboratory-specific QC materials are still used, there is added value in using commercial materials continuously available to all laboratories regardless of instrumentation and geographic location. Broadly, QC materials fall into one or more of the categories defined above (QC1, QC2, QC3, and QC4) and will be discussed here in terms of increasing complexity (and listed in Table 1).
Peptides
The simplest and most accurately characterized QC materials are mixtures of synthetic peptides, including those that have been isotopically labeled to avoid interference with peptides from the samples (Table 1). Isotopically labeled or unlabeled, these peptide mixes fall under the QC1 category. The Pierce Peptide Retention Time Calibration Mixture, Biognosys iRT Kit, and Sigma-Aldrich MSRT1 standard are good examples, providing a mixture of unlabeled nonendogenous peptides that elute over a reverse phase gradient. These can be used to monitor chromatographic performance during the run but also post-acquisition retention time normalization (or calibration into a universal retention time scale). Mixtures of differentially isotopically labeled peptides are useful for checking quantitative accuracy and detection limits, which include the Pierce LC-MS/MS System Suitability Standard (7 x 5 mixture), Promega 6 x 5 LC-MS/MS Peptide Reference Mix, and the Sigma-Aldrich MSQC1 calibration standard for multiple-reaction monitoring (MRM) analyses. Due to the relative simplicity of these mixtures, they are normally spiked into a sample background or, in the case of retention time standards, into every sample. They can be spiked into digested proteome QC materials (QC2) to create a QC3 (described below). These peptide mixtures provide very specific QC information, which can easily be extracted in automated data analyses and often have associated QC software (described below). Depending on when in the process the peptides are added, they may provide different QC information on the experimental workflow. For instance, if the peptides are spiked into a sample following digestion but before peptide cleanup, the spike levels can be used to evaluate losses in the cleanup, which is critically important in samples with low protein concentration or single-cell analyses.32 Spiking into the sample earlier covers more steps of the experiment but increases the ambiguity in the QC results when something goes wrong and may necessitate additional analyses during troubleshooting. Peptides should be spiked in as early as necessary and as late as possible to bracket experimental steps.
Proteins
As an alternative to peptide mixtures, but still relatively simple, purified undigested proteins can also be used for QC (Table 1). When undigested, these fall in the QC2 category, and unlike QC1 level peptides, they can be used to provide information on the efficiency of reduction, alkylation, and digestion. A good example is the QconCAT33 method, in which a protein is made from a genetic construct, concatenating peptides into a protein that is added to samples to control for variability in reduction, alkylation, and digestion. The resulting peptides can be chosen from proteins targeted for quantitation by MRM and the entire protein inexpensively isotopically labeled for the resulting peptides to be used as internal standards. If the concatenated peptides span the chromatographic separation, they can also be used for retention time calibration and LC monitoring.34, 35 Open-source software can be used to design these concatenated constructs.36,37 In addition to QconCATs, pure proteins with well-characterized modifications can be used to evaluate the enrichment and detection of phospho- or glycoproteins, such as 0-casein for phosphoproteomics or ribonuclease B (high mannose type glycans) and bovine fetuin (complex, sialylated glycans) for glycoproteomics, though their lack of complexity limits their utility in providing more complex QC metrics. To generate a larger number of peptides than a single protein and provide a useful QC material for protein separation or fractionation methods, mixtures of a limited number of purified proteins have been designed as standards for proteomics and made commercially available. These include the abovementioned UPS1 and UPS2 standards of 48 proteins as well as the simpler UPS3 standard of 8 nonhuman proteins spanning 4 orders of magnitude in concentration. To evaluate protein inference in downstream data analysis workflows, mixtures of proteins with known shared and unique peptides can be used. Examples of such mixtures include those used in the 2016 ABRF Proteome Informatics Research Group study.38,39 These protein/proteome mixtures are more complex, and their analysis is less straightforward than simple peptide mixtures. Unless isotopically labeled, they likely also interfere with endogenous proteins in experimental samples and are therefore not suitable spikes. Their direct support by data analysis software is also less trivial than the simple peptide mixtures, as they do not necessarily contain a small set of peptides expected to be observed in each run. More examples are listed in Table 1.
Proteomes
With the latest generation instrumentation, over 5,000 proteins can be detected in a matter of minutes,40,41 and median protein coverage of 79% across the complete proteome42 (reviewed in ref. 43), using whole proteomes as QC, is becoming increasingly attractive and falls under the QC2 category. The benefit of using whole proteomes as QC materials is that the dynamic range of proteins in a proteome inherently covers many orders of magnitude, and the unattainable complete proteome coverage means that the performance scale should remain beyond instrument performance (that is, until vendors begin promising complete proteome coverage), allowing future comparisons of performance across system upgrades or when acquiring new mass spectrometers. Whole proteomes are also useful since they can track the complete experiment from digestion to data analysis and can be used with any protease. Having a material that includes extraction is valuable, as extraction can account for the majority of technical variability.22 One notable proteome is the NIST RM 8461 (Human Liver for Proteomics), which is a relatively low-cost room temperature stable powder still requiring lysis and digestion.44 There are other NIST materials containing proteins that may be similarly fit for purpose such as yeast protein extract (RM 832345), or not specifically fit for proteomics like NIST SRM 1950 (Metabolites in Frozen Human Plasma), both of which are ready to digest. It is important to highlight that Promega provides paired digested and undigested proteomes, thus providing an additional opportunity for QC (Table 1).
Proteins and proteome digests
Predigested and purified protein (QC1) and proteome (QC2) digests are convenient as materials for LC-MS/MS QC, as they are quickly prepared for injection. Lyophilized digests are also shelf stable for long time periods and easy to distribute between laboratories. Commercially available digests of proteins and proteomes are listed in Table 1. Of specific note are whole-proteome digests that can be purchased along with the undigested version (e.g., Promega’s mass spectrometry-compatible protein extracts of yeast and human K562 cells and PolyQuant’s RePLiCal QconCAT protein34), thus adding an additional opportunity for checking experimental QC. The 2022 sPRG study mixed proteomes of human liver (NIST RM 8461), cow liver (NIST SRM 1577c), and trout tissue (NIST SRM 1947) in different ratios with plans to make both digested and lysate mixes available in the near future (note that these mixtures are no longer considered NIST materials, and their use in proteomics is beyond the original intent of the materials). Moreover, there are isotopically labeled proteomes such as the Pierce TMT11 yeast digest and the TKOpro9 and TKOpro1646 standards created to evaluate relative quantitation using TMT.
Blended materials
Two or more well-defined materials for QC1 or QC2 can be combined to make bespoke but still well-defined materials for QC3 or QC4. Protein or proteome digests can be combined in known ratios for quantitative QC. 47,48 Spiking peptides into a lysate or digest provides additional utility, for example, for simple chromatography and mass measurement quality control. The drawback of custom mixed standards versus commercially available premixed standards is that since they are only in their respective components, users must mix their own, meaning that data from these mixes varies across laboratories. However, some vendors now sell premixed QC1/QC2 materials, such as HeLa digests with PRTC Standard. Lastly, though we have described QC4 materials above (i.e., a suite of QC2 materials), there are currently no commercially available suites of materials for proteomics that fit this definition (aside from the sPRG suite currently in development). Arguably, the Pierce TMT11plex Yeast Digest provides similar utility as a true QC4; however, as it is prelabeled, it cannot be used to assess quantification across the complete experimental workflow. That said, there are many suites of biological materials available from NIST that could fit this need, albeit they are not explicitly listed as fit for purpose for proteomics. These include NIST SRM 1949 (Frozen Human Prenatal Serum), NIST Candidate RM 8231 (Frozen Human Plasma Suite for Metabolomics), NIST Candidate RM 8232 (Frozen Human Urine Suite for Metabolomics), and NIST Candidate RM 8462 (Frozen Human Liver Suite for Omics; “candidate” refers to materials near the end of the development cycle that are likely available soon, but not as of September 2024). We see QC4 suites as an opportunity for future development, which may include a demonstration of proteomics fit for purpose in existing suites or the creation and distribution of new suites.
Application-specific materials
Even though most of these QC materials are related to typical bottom-up proteomics measurements (including using isotopic labeling or DIA), there are materials for niche applications. Well-characterized monoclonal antibodies from Sigma-Aldrich and NIST have been used in large interlaboratory studies of top-down proteomics and glycosylation analysis.49,50 For metaproteomics, mock microbial communities such as ZymoBIOMICS Microbial Community Standards, ATCC whole-cell mixes, and those created in the Critical Assessment of MetaProteome Investigation studies (https://metaproteomics.org/campi/) can be used for QC and SST.51 Note that ZymoBIOMICS and ATCC mock communities are available as cell lysates and DNA extracts, with the latter unsuitable for proteomics. Additional complex microbial materials, such as NIST Candidate RM 8048 (Human Fecal Material), are under development . In glycoproteomics, commercially available antibodies as well as many of the proteomes already mentioned can be used, either directly, after releasing glycans, or following enrichment of glycoproteins or glycopeptides. Glycan spectra from NIST RM 8671 (NISTmAb, Humanized IgG1K Monoclonal Antibody) and the NIST SRM 1953 (Organic Contaminants in Non-Fortified Human Milk) are already in the NIST mass spectral reference libraries, helping provide a benchmark for these specific materials. Commercially available purified glycan standards include a long list of AdvanceBio N-glycans individually available from Agilent and a set of 13 abundant and commonly identified N-linked IgG glycans in the NIST SRM 3655 (Glycans in Solution).
BENCHMARK DATA
Public datasets from commercially available materials are valuable complements to the physical materials, allowing direct comparison and benchmarking of experimental methods, instruments, and data analysis workflows using ground truth data. They also allow the construction of spectral libraries from externally acquired data that can be used to quickly identify peptides from one’s own data. Datasets from the ABRF RG studies, including those from sPRG studies resulting in commercially available standards, have seen frequent reuse by researchers developing new algorithms and software.53,54,55,56,57,58,59,60,61,62, 63,64,65,66,67,68,69,70,71,72,73,74 Ground-truth datasets generated from no longer available (but in principle, reproducible) material can be used in core laboratories to evaluate new software, software updates, new processing hardware, or even just new search parameters and databases without having to analyze additional QC samples. A versatile dataset for checking and comparing data analysis workflows include ProteomeXchange dataset PXD007683 from a comparison of protein quantification methods by O’Connell et al.75 Ideally, the methods and instrumentation that were used to generate the QC dataset are very similar to those in one’s own laboratory. Datasets from well-defined metaproteomes are also available, even if the material is not, such as PXD005776, PXD005759, and PXD005728 from the 24 bacterial species in the Mix24X reference76 or the PXD034795 dataset from the 2020 Proteome Informatics Research Group metaproteomics study.77
METHODS FOR IMPLEMENTING QC
As described above, the QC level of a material dictates how and when it may be used, which in turn determines what information it can provide. Similarly, when the QC material is used, it establishes QC metric points in time, which is essential before and during an experiment. Specific approaches to using QC materials within an experiment itself are important to discuss. In addition to SST before the experimental run has started, QC materials can be used within runs to monitor changes in instrument performance. As a general heuristic, 1 out of every 20 samples should include some sort of QC check (i.e., 5% of samples are QC samples). This simple guideline does not replace the importance of proper experimental design and sample randomization. The QC samples may reveal batch effects,4,78 but they will not automatically correct them. Since replicates will be mentioned, for this paper we define them as follows: experimental replicate is a sample that was processed and analyzed independently more than once; technical replicate is a sample that was processed once, but repeat measurements were taken on the instrument. More detailed descriptions and discussions of experimental design and QCs such as block designs can be found here3,4,78,79 as well as a turn-key tutorial for running QC in label-free quantitative proteomics experiments80 or implementation in isobaric tagging experiments.81 The different commercially available QC materials that have been described in the sections above may be referred to as external QC (EQC), to differentiate this type of QC from a study pool QC (SPQC). A SPQC would be a QC2 level material but is laboratory (and experiment) specific and not commercially available. In general, the use of both EQC and SPQC samples is important. In a multi-well plate format, the EQC and SPQC can be spaced between samples,3,79 related to upstream process batching if needed (though these same concepts can be applied within a normal sample queue as well as a plate format). Within plates it is also important to consider the location of samples to capture effects within the plate, such as the unequal effect of heating during protein digestion.82 Finally, when analyzing multiple plates, the same concepts of block design and normalization apply,4,78 and the use of QC materials can be essential to implementing, especially when the desire is to compare to historical datasets or those collected in other laboratories.6
QC METRICS
Up to this point, we have discussed why QC is important, what materials are available, and how to incorporate them into experiments. Foremost, QC attempts to quantify instrument and experimental performance to give confidence to the validity, uncertainty, and accuracy of the resulting data. Secondary to this, QC metrics can be used to troubleshoot issues in sample preparation, data acquisition, and data analysis. We will not go into specifics on what a deviation of QC metrics can indicate, but bracketing experimental and analytical steps with different QCs will aid in problem isolation. Also collecting longitudinal QC data is essential at defining acceptable norms for technical variation (i.e., statistical process control).
Coarse measures of system performance, such as “number of peptide spectral matches” of a known sample on a known gradient, are considered insufficient, since such metrics can mask underlying issues with the system, leading to false confidence, or simply not provide any actionable troubleshooting if the metric is too low. Therefore, there is a desire to provide more granular metrics, which include identity-free (ID-free) and ID-based metrics, covering protein extraction, digestion efficiency, chromatographic separation, ion mobility, MS, MS/MS, and peptide and protein quantification. The ID-free metrics are those metrics that can be computed independently of identifying any peptides and cover aspects such as column pressure, electrospray stability, chromatographic peak width, overall signal (total ion chromatograms), mass measurement precision, and charge state distribution.83 Through direct comparisons of tandem mass spectra, the similarity between LC-MS/MS datasets can also be evaluated and used for experimental QC.84 ID-based metrics are those reliant on peptide identification and include chromatographic reproducibility, mass measurement accuracy, collision energy, peptide identification rate, and most quantitative QC metrics. This general dichotomy is useful to separate QC metrics into those that can be calculated immediately from the data, making few or no assumptions, from those that first require running a data analysis pipeline, making many assumptions, in order to calculate the QC metrics. The former are more primitive, although their calculation is highly reliable and independent of search space (i.e., FASTA) or search algorithm. The latter are likely more relevant for data interpretation but dependent on assumptions being correct, for example, a calculation of the efficiency of enzymatic digestion will not yield meaningful results if no missed cleavages were allowed in the database search. This is a trivial example, but data analysis methods also influence ID-based QC metrics in less conspicuous ways; for example, the mass measurement error tolerance in the database search determines which set of peptides are identified and, in turn, which peptides are used to calculate mass measurement accuracy.
For this brief discussion of QC metrics, we recommend going back to arguably the start of mass spectrometrybased proteomics QC with the now defunct NIST MSQC, developed in 2010 to support Clinical Proteomic Tumor Analysis Consortium (CPTAC) efforts.1,85 The NIST MSQC included 46 metrics, which have since been expanded in numerous derived applications, such as QuaMeter,86 and modeling-based metrics.2 Shortly thereafter in 2012 with SIMPATIQCO,87 there was also progress made for automatically uploading files into such QC programs, making longitudinal reports and dashboards possible in an automatic way, a concept that is still being used in more recent QC software (Table 2). In general, these early metrics focused solely on the system performance using a blend of ID-free and ID-based metrics, but depending on the QC material used, additional metrics can be derived. For instance, LC separation performance and drift can be monitored using retention time standards like the PRTC or iRT; albeit, using IDs of endogenous peptides themselves can also provide metrics by modeling retention times.6,88 When proteins or proteomes are used, true digestion efficiency can be calculated along with ID-based metrics like tryptic miscleavage rates to accurately qualify digestion performance. Additionally, quantitative standards can be used to determine detection limits, either of a targeted assay (Pierce System Suitability Standard 7 x 5 mixture) or of isobaric labels (TMT11 yeast digest). Moreover, different data acquisition techniques may give unique performance measures, such as isotopic and isobaric labeling, that can capture labeling efficiency and channel missingness. 89,90 These metrics are useful in that when there is a problem between sample processing and data analysis, troubleshooting can be directed by the results.
Table 2. Select Tools and Resources, Including Dedicated Software and Templates, for QC in Proteomics Core Facilities.
|
Software |
MS data acquisition type |
Input data format |
QC levels |
bio.tools entry |
Associated QC material(s) |
|---|---|---|---|---|---|
|
AutoQC80 |
targeted, DDA, DIA |
Thermo RAW, mzXML, mzML |
QC1, QC2, QC3 |
panorama |
Tutorials with Pierce System Suitability Standard (7 x 5 mixture)80 |
|
MaCProQC 100 |
DDA |
Thermo RAW, mzML |
QC2 |
MaCProQC |
|
|
MSstatsQCgui |
targeted, DDA, DIA |
search results as tsv or mzTab |
QC1, QC2, QC3 |
MSstatsQC |
|
|
MsQuality |
DDA |
Thermo RAW, mzML, mzXML, MGF, other |
- |
MsQuality |
|
|
DDA, DIA |
R data object of peptide intensities (can use MSNbase output) |
QC2 |
pmartR |
||
|
pmultiqc97 |
DDA, DIA |
mzML, SDRF, mzTab |
QC1, QC2, QC2 |
pmultiqc |
|
|
PReMiS |
DDA |
Thermo raw, Sciex wiff, mzML |
QC1, QC2, QC3 |
PReMiS |
Promega 6 x 5 Peptide Reference Mix |
|
ProteomicsQC |
DDA |
Thermo RAW |
QC2 |
ProteomicsQC |
|
|
Proxl105 |
DDA (crosslinking) |
proxl XML file (converted from other software outputs) |
QC2 |
proxl |
|
|
PTXQC106 |
DDA |
search results as tsv (Maxquant) or mzTab (OpenMS) |
QC2 |
PTXQC |
|
|
QC-ART107 |
DDA |
QC metrics by injection |
QC2 |
QC-ART |
|
|
DDA |
Thermo RAW |
QC1, QC2, QC3 |
QCloud2 |
Currently BSA and HeLa only |
|
|
QuaMeter |
DDA |
mzML |
QC1, QC3 |
QuaMeter |
BSA, β-galactosidase, yeast lysate |
|
QuiC |
targeted, DDA, DIA |
any vendor format |
QC1, QC2, QC3 |
QuiC |
Biognosys iRT |
|
Rapid QC-MS 110 |
DDA |
Any vendor by built-in msconvert |
QC1, QC2, QC3 |
Rapid-QC-MS |
|
|
RawBeans 111 |
DDA, DIA |
Thermo RAW natively, others by built-in msconvert |
QC1, QC2, QC3 |
RawBeans |
|
|
RawHummus 112 |
DDA |
mzML, mzXML |
QC1, QC2, QC3 |
RawHummus |
|
|
SimpatiQCo 87 |
DDA |
Thermo RAW |
SimpatiQCo |
||
|
SProCoP5 |
targeted, DIA |
Skyline .sky files |
QC1, QC2, QC3 |
SProCoP |
|
|
TVT2.5113 |
DDA |
Thermo RAW |
QC1, QC2, QC3 |
tvt viewer |
Pierce TMT11plex Yeast Digest |
In addition to capturing metrics per injection or experiment, it is essential to monitor these metrics longitudinally. These QC metrics can vary by LC column chemistry and flow rates, data acquisition type, and instrument platforms, and so defining acceptable margins is imperative.5 It may be that some acceptable range of +/- 15% of a QC metric is acceptable, but anything outside this range would need the run to stop (a go/no-go metric). Defining these margins truly relies on an operator’s knowledge and experience with their specific setup and how these quality metrics manifest in the final data analysis (i.e., there are some metrics that do not have universal thresholds for QC). Being able to track values across long periods of time will invariably help if troubleshooting the system is needed, or to determine the need for periodic maintenance. This is also a case when sharing data between laboratories of the same material and same data acquisition can be helpful, since this way, drift in instrument performance and data quality can be compared across similar setups.
Finally, new quality metrics continue to be defined and implemented for specific use cases. For example, quantifying technical contaminants in samples (such as polymers and detergents91) is important but frequently overlooked. Tools that address this include mzsniffer (https://github. com/wfondrie/mzsniffer), custom Skyline templates,92 and HowDirty.93 Likewise, these concepts and tools could be applied to other informative contaminants, such as siloxane bleeding off columns. Similarly, there are QC tools for specific sample types, for instance, tools to evaluate plasma sample quality (http://www.plasmaproteomeprofiling.org/). 94 Moreover, as instruments improve and more readbacks are available, we expect there to be new metrics related to anything from spray voltage to ion mobility and single-ion detection. Each quality metric will improve our ability to define the normal and detect deviation from it.
QC SOFTWARE AND TOOLS
There is a plethora of QC scripts and tools described in the literature as “written in house,” without much further detail. For the sake of the mass spectrometry proteomics core, this discussion will focus on software and tools that are reasonably FAIR (Findable, Accessible, Interoperable, and Reusable)95 and currently (December 15, 2023) usable with minimal setup. This includes most of the tools described in the bio.tools registry. Out of a total of 375 “quality control” software tools, 32 belong to the “Proteomics” domain (https://bio.tools/t?page=1&q=%27Quality%20control%27%2B%27Proteomics%27&sort=score). We list a few we consider to be of particular use in core laboratories and will note which software does and does not work within strict security and data privacy limitations. This table is by no means exhaustive and is complemented by an online database we make available on https://osf.io/nze34. To begin with, some software tools depend on a certain spike-in or QC material. For instance, QuiC (Biognosys) is a standalone software made for data containing the iRT peptide spike and is able to track QC metrics longitudinally. Although from a commercial company, this software is free to use and generates many of the ID-free and ID-based metrics discussed above using DDA, DIA, or targeted (i.e., SRM/PRM) analyses. The triple knockout visualization tool (TVT)46,96 is a web portal that takes Thermo raw files as input. Though originally developed for the TMT11plex yeast material, the current version (2.5) supports all commercially available TMT sets up to and including TMT Pro 18-plex. The TVT provides numerous ID-based metrics using the known knockout proteomes while also providing ID-free metrics like peak widths and injection time and the ability to compare metrics between runs. Another material with associated software is the Promega 6 x 5 spike-in, which can be used along with PReMiS software. Lastly, though AutoQC can work with nearly anything with endless customization, numerous resources and templates are available to work specifically with the Pierce LC-MS/MS System Suitability Standard (7 x 5 mixture). More recent is the Bruker TwinScape “digital twin” collecting QC data based on the Biognosys iRT kit on a cloud for longitudinal visualization in dashboards, although not included in Table 2 as it is commercial software. Coupling these QC materials and QC software tools lower the energy activation to get QC setup in the core (see Recommendations section).
Other software and tools typically can use any QC material to generate and track QC metrics, although they still may benefit from peptide spike-ins. For instance, the commercial software AutoQC Loader has built-in templates to use data from the Pierce LC-MS/MS System Suitability Standard (7 x 5 mixture). This generates specific metrics related to detection limits and retention time, but even without this spike-in, Panorama QC can also generate reports of ID-free and ID-based metrics as a function of time (analysis). Likewise, a free local or web-based option is QCloud2, which can track QC metrics over time for multiple instruments and QC materials, and acceptable performance margins can be set. Both RawHummus and QCloud2 can be set up locally and still accessed via a browser, but some knowledge of setting up and running containers is needed. The pmultiqc is a new tool integrated into the quantms workflow97 based on the popular genomics QC tool multiqc98 and using pyOpenMS and OpenMS tools.99 This python-based tool generates QC reports that are easily shareable as html web pages, with metrics at the level of the MS1 and MS2 spectra and at the peptide and protein level. Overall, the specific software listed in Table 2 are easily installed, often have GUIs, and have adequate developer support to get any laboratory quickly up and running QC.
These software are free to use, actively maintained, and functional, and many are also open source. The latter is essential for transparency on how QC benchmarks are derived from measurements. “Targeted” under “MS data acquisition type” refers to targeted data acquisition such as SRM, MRM, and PRM. The bio.tools entries contain additional information on software licenses, documentation, specific types of analysis operations performed by the software, input and output data types, and file formats. A more complete software list can be found in an online database we make available on https://osf.io/nze34.
Some tools, such as those in the TVT series, require data to be uploaded to a server. This is convenient, as it can be used from data acquisition computers without the need to install additional software, and results can be viewed in a web browser, as long as the computers are connected to the internet. For laboratories operating under tighter security or where data privacy is of concern, most of the above software can be installed and run on computers not directly connected to the internet. We note that data from QC samples interspersed with experimental samples may contain carryover from those samples, especially when run immediately after a sample. In this scenario, the QC sample could also be used to quantify carry-over (i.e., abundant peptides from experimental samples could be tracked in the QC sample). However, and more critically, this observation of carryover can also mean that the same privacy and security concerns that apply to data from experimental samples may also apply to the data from the QC samples. Overall, there is an abundance of software choices that could work within most limitations.
FUTURE DIRECTIONS
It is evident that there are a plethora of materials, metrics, and software tools to incorporate QC in the core laboratory. Still, there are much needed advancements on the horizon that will make this even easier by improving the interoperability and reusability of QC. For instance, as the mzQC standard is finalized and adopted (https://psidev.info/mzqc), it will become easier to compare, combine, and track QC metrics from different software tools into custom QC reports fit for the laboratory, study, or analysis as well as deposit this information alongside experimental data.114 The idea of universal QC, a radical concept discussed in depth during a 2022 Lorentz Center Workshop on proteomics and machine learning,115 is that one day researchers will be able to generate realistic synthetic data matching every sample, analytical procedure, and instrumentation in order to evaluate the quality of any dataset without commercial QC standards, making each sample its own QC sample. Such integrated models for synthetic data generation may still be a few years away from being implemented in core laboratories, but once they are, they will immediately provide a framework for computing many informative QC metrics based on the analysis results. Until we reach this point, the availability of a wide range of QC materials across QC levels coupled with QC software should enable any proteomics mass spectrometry core to generate QC metrics of their complete process, helping troubleshoot when needed and lending confidence in delivered results.
RECOMMENDATIONS
This paper has hopefully provided helpful information about commercially available QC materials and how they might be used in a core setting. Although we touch on special use cases such as metaproteomics, we would like to provide a general starting recommendation to a core providing discovery or quantitative proteomics services. First, choose a software option from Table 2 and load in data from your instrument(s), or use the relevant available datasets (Table 1) to evaluate the software-generated reports. These reports should help you decide if an injection is acceptable and, if not, help troubleshoot why not as well as be something that can be shared with end-users. Some software may rely on a technique you do not use (i.e., TVT2.5 is for TMT), and other software may not provide a desired feature (i.e., some focus more on longitudinal-based statistical process control). Once software has been selected, purchase the requisite material (likely a QC1 spike, or QC2/QC3 material), and begin to implement it in your core using the Methods for Implementing QC section as a starting point. The sooner you begin collecting QC metrics, the more historical information you will have to rely on.
ACKNOWLEDGMENTS
The authors wish to thank Christopher Ashwood for insight on commonly used materials in glycan and glycoproteomic analysis, Lindsay Pino for general discussions and expert insight, specifically about AutoQC, Matt Foster for a real-world QC perspective, and Clay Davis for assistance in navigating the NIST SRM catalog. We also wish to thank the reviewers of this manuscript for their time, energy, and essential feedback. These opinions, recommendations, findings, and conclusions do not necessarily reflect the views or policies of NIST or the United States Government. Identification of certain commercial equipment, instruments, software, or materials does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the products identified are necessarily the best available for the purpose. Yasset Perez-Riverol would like to acknowledge funding from Wellcome (Grant Number 208391/Z/17/Z) and European Molecular Biology Laboratory core funding.
Funding Statement
The authors wish to thank Christopher Ashwood for insight on commonly used materials in glycan and glycoproteomic analysis, Lindsay Pino for general discussions and expert insight, specifically about AutoQC, Matt Foster for a real-world QC perspective, and Clay Davis for assistance in navigating the NIST SRM catalog. We also wish to thank the reviewers of this manuscript for their time, energy, and essential feedback. These opinions, recommendations, findings, and conclusions do not necessarily reflect the views or policies of NIST or the United States Government. Identification of certain commercial equipment, instruments, software, or materials does not imply recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that the products identified are necessarily the best available for the purpose. Yasset Perez-Riverol would like to acknowledge funding from Wellcome (Grant Number 208391/Z/17/Z) and European Molecular Biology Laboratory core funding.
References
- 1.Rudnick PA, Clauser KR, Kilpatrick LE, et al. Performance metrics for liquid chromatography-tandem mass spectrometry systems in proteomics analyses. Mol Cell Proteomics. 2010;9(2):225-241. doi: 10.1074/mcp.M900223-MCP200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Tabb DL. Quality assessment for clinical proteomics. Clin Biochem. 2013;46(6):411-420. doi: 10.1016/j.clinbiochem.2012.12.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Bittremieux W, Tabb DL, Impens F, et al. Quality control in mass spectrometry-based proteomics. Mass Spectrom Rev. 2018;37(5):697-711. doi: 10.1002/mas.21544 [DOI] [PubMed] [Google Scholar]
- 4.Cairns DA. Statistical issues in quality control of proteomic analyses: good experimental design and planning. Proteomics. 2011;11(6):1037-1048. doi: 10.1002/pmic.201000579 [DOI] [PubMed] [Google Scholar]
- 5.Bereman MS, Johnson R, Bollinger J, et al. Implementation of statistical process control for proteomic experiments via LC MS/MS. J Am Soc Mass Spectrom. 2014;25(4):581-587. doi: 10.1007/s13361-013-0824-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Abbatiello SE, Mani DR, Schilling B, et al. Design, implementation and multisite evaluation of a system suitability protocol for the quantitative assessment of instrument performance in liquid chromatographymultiple reaction monitoring-MS (LC-MRM-MS). Mol Cell Proteomics. 2013;12(9):2623-2639. doi: 10.1074/mcp.M112.027078 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Colangelo CM, Chung L, Dufresne C, et al. Development & characterization of SpikeMix ABRF (Cross-Species Standard) consisting of 1,000 stable isotope labeled peptides. JPT Peptide Technologies. March 2014. Accessed August 29, 2024. https://www.jpt.com/media/90/f2/59/1617873845/AppNote_Proteomics_SpikeMix_ABRF_SIL_Peptides.pdf
- 8.Searle BC, Chien A, Koller A, et al. A multipathway phosphopeptide standard for rapid phosphoproteomics assay development. Mol Cell Proteomics. 2023;22(10):100639. doi: 10.1016/j.mcpro.2023.100639 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Käll L, Canterbury JD, Weston J, Noble WS, MacCoss MJ. Semi-supervised learning for peptide identification from shotgun proteomics datasets. Nat Methods. 2007;4(11):923-925. doi: 10.1038/nmeth1113 [DOI] [PubMed] [Google Scholar]
- 10.Buur LM, Declercq A, Strobl M, et al. MS(2)Rescore 3.0 is a modular, flexible, and user-friendly platform to boost peptide identifications, as showcased with MS Amanda 3.0. J Proteome Res. 2024;23(8):3200-3207. doi: 10.1021/acs.jproteome.3c00785 [DOI] [PubMed] [Google Scholar]
- 11.Chapter 5: Calibration. In: Balke ST, ed. Journal of Chromatography Library. Vol 29. Elsevier; 1984:193-240. [Google Scholar]
- 12.Bylund D, Danielsson R, Malmquist G, Markides KE. Chromatographic alignment by warping and dynamic programming as a pre-processing tool for PARAFAC modelling of liquid chromatography-mass spectrometry data. Journal Chromatogr A. 2002;961(2):237-244. doi: 10.1016/s0021-9673(02)00588-5 [DOI] [PubMed] [Google Scholar]
- 13.Lipton MS, Pasa-Tolic L, Anderson GA, et al. Global analysis of the Deinococcus radiodurans proteome by using accurate mass tags. Proc Natl Acad Sci. 2002;99(17):11049-11054. doi: 10.1073/pnas.172170199 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Palmblad M, Mills DJ, Bindschedler LV, Cramer R. Chromatographic alignment of LC-MS and LC-MS/MS datasets by genetic algorithm feature extraction. J Am Soc Mass Spectrom. 2007;18(10):1835-1843. doi: 10.1016/j.jasms.2007.07.018 [DOI] [PubMed] [Google Scholar]
- 15.Palmblad M, Bindschedler LV, Gibson TM, Cramer R. Automatic internal calibration in liquid chromatography/Fourier transform ion cyclotron resonance mass spectrometry of protein digests. Rapid Commun Mass Spectrom. 2006;20(20):3076-3080. doi: 10.1002/rcm.2707 [DOI] [PubMed] [Google Scholar]
- 16.Geiger T, Cox J, Mann M. Proteomics on an Orbitrap benchtop mass spectrometer using all-ion fragmentation. Mol Cell Proteomics. 2010;9(10):2252-2261. doi: 10.1074/mcp.M110.001537 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Bouwmeester R, Martens L, Degroeve S. Generalized calibration across liquid chromatography setups for generic prediction of small-molecule retention times. Anal Chem. 2020;92(9):6571-6578. doi: 10.1021/acs.analchem.0c00233 [DOI] [PubMed] [Google Scholar]
- 18.Hermjakob H, Apweiler R. The Proteomics Identifications Database (PRIDE) and the ProteomExchange Consortium: making proteomics data accessible. Expert Rev Proteomics. 2006;3(1):1-3. doi: 10.1586/14789450.3.1.1 [DOI] [PubMed] [Google Scholar]
- 19.Li YF, Arnold RJ, Tang H, Radivojac P. The importance of peptide detectability for protein identification, quantification, and experiment design in MS/MS proteomics. J Proteome Res. 2010;9(12):6288-6297. doi: 10.1021/pr1005586 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Jagtap P, Goslinga J, Kooren JA, et al. A two-step database search method improves sensitivity in peptide sequence matches for metaproteomics and proteogenomics studies. Proteomics. 2013;13(8):1352-1357. doi: 10.1002/pmic.201200352 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Lee EM, Srinivasan S, Purvine SO, et al. Optimizing metaproteomics database construction: lessons from a study of the vaginal microbiome. mSystems. 2023;8(4):e0067822. doi: 10.1128/msystems.00678-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Piehowski PD, Petyuk VA, Orton DJ, et al. Sources of technical variability in quantitative LC-MS proteomics: human brain tissue sample analysis. J Proteome Res. 2013;12(5):2128-2137. doi: 10.1021/pr301146m [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Hu A, Noble WS, Wolf-Yadlin A. Technical advances in proteomics: new developments in data-independent acquisition. F1000Research. 2016;5. doi: 10.12688/f1000research.7042.1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Ross PL, Huang YN, Marchese JN, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics. 2004;3(12):1154-1169. doi: 10.1074/mcp.M400129-MCP200 [DOI] [PubMed] [Google Scholar]
- 25.Thompson A, Schäfer J, Kuhn K, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem. 2003;75(8):1895-1904. doi: 10.1021/ac0262560 [DOI] [PubMed] [Google Scholar]
- 26.Lippa KA, Aristizabal-Henao JJ, Beger RD, et al. Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC). Metabolomics. 2022;18(4):24. doi: 10.1007/s11306-021-01848-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Broadhurst D, Goodacre R, Reinke SN, et al. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies. Metabolomics. 2018;14(6):72. doi: 10.1007/s11306-018-1367-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.McDonnell LA, Heeren RM. Imaging mass spectrometry. Mass Spectrom Rev. 2007;26(4):606-643. doi: 10.1002/mas.20124 [DOI] [PubMed] [Google Scholar]
- 29.Wiseman JM, Ifa DR, Song Q, Cooks RG. Tissue imaging at atmospheric pressure using desorption electrospray ionization (DESI) mass spectrometry. Angew Chem Int Ed Engl. 2006;45(43):7188-7192. doi: 10.1002/anie.200602449 [DOI] [PubMed] [Google Scholar]
- 30.Föll MC, Volkmann V, Enderle-Ammour K, et al. Moving translational mass spectrometry imaging towards transparent and reproducible data analyses: a case study of an urothelial cancer cohort analyzed in the Galaxy framework. Clin Proteomics. 2022;19(1):8. doi: 10.1186/s12014-022-09347-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Lilley KS, Deery MJ, Gatto L. Challenges for proteomics core facilities. Proteomics. 2011;11(6):1017-1025. doi: 10.1002/pmic.201000693 [DOI] [PubMed] [Google Scholar]
- 32.Gatto L, Aebersold R, Cox J, et al. Initial recommendations for performing, benchmarking and reporting single-cell proteomics experiments. Nat Methods. 2023;20(3):375-386. doi: 10.1038/s41592-023-01785-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Pratt JM, Simpson DM, Doherty MK, Rivers J, Gaskell SJ, Beynon RJ. Multiplexed absolute quantification for proteomics using concatenated signature peptides encoded by QconCAT genes. Nat Protoc. 2006;1(2):1029-1043. doi: 10.1038/nprot.2006.129 [DOI] [PubMed] [Google Scholar]
- 34.Holman SW, McLean L, Eyers CE. RePLiCal: a QconCAT protein for retention time standardization in proteomics studies. J Proteome Res. 2016;15(3):1090-1102. doi: 10.1021/acs.jproteome.5b00988 [DOI] [PubMed] [Google Scholar]
- 35.Eyers CE, Simpson DM, Wong SC, Beynon RJ, Gaskell SJ. QCAL--a novel standard for assessing instrument conditions for proteome analysis. J Am Soc Mass Spectrom. 2008;19(9):1275-1280. doi: 10.1016/j.jasms.2008.05.019 [DOI] [PubMed] [Google Scholar]
- 36.Rusilowicz M, Newman DW, Creamer DR, et al. AlacatDesigner—computational design of peptide concatamers for protein quantitation. J Proteome Res. 2023;22(2):594-604. doi: 10.1021/acs.jproteome.2c00608 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Lebert D, Louwagie M, Goetze S, et al. DIGESTIF: a universal quality standard for the control of bottom-up proteomics experiments. J Proteome Res. 2015;14(2):787-803. doi: 10.1021/pr500834z [DOI] [PubMed] [Google Scholar]
- 38.The M, Edfors F, Perez-Riverol Y, et al. A protein standard that emulates homology for the characterization of protein inference algorithms. J Proteome Res. 2018;17(5):1879-1886. doi: 10.1021/acs.jproteome.7b00899 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lee JY, Choi H, Colangelo CM, et al. ABRF Proteome Informatics Research Group (iPRG) 2016 study: inferring proteoforms from bottom-up proteomics data. J Biomol Tech. 2018;29(2):39-45. doi: 10.7171/jbt.18-2902-003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Skowronek P, Thielert M, Voytik E, et al. Rapid and in-depth coverage of the (Phospho-)Proteome with deep libraries and optimal window design for dia-PASEF. Mol Cell Proteomics. 2022;21(9):100279. doi: 10.1016/j.mcpro.2022.100279 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Szyrwiel L, Gille C, Mülleder M, Demichev V, Ralser M. Fast proteomics with dia-PASEF and analytical flow-rate chromatography. Proteomics. 2024;24(1-2):e2300100. doi: 10.1002/pmic.202300100 [DOI] [PubMed] [Google Scholar]
- 42.Sinitcyn P, Richards AL, Weatheritt RJ, et al. Global detection of human variants and isoforms by deep proteome sequencing. Nature Biotechnol. 2023;41(12):1776-1786. doi: 10.1038/s41587-023-01714-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Peters-Clarke T, Coon J, Riley N. Instrumentation at the leading edge of proteomics. Anal Chem. 2024;96(20):7976-8010. doi: 10.1021/acs.analchem.3c04497 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Davis WC, Kilpatrick LE, Ellisor DL, Neely BA. Characterization of a human liver reference material fit for proteomics applications. Sci Data. 2019;6(1):324. doi: 10.1038/s41597-019-0336-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Beasley-Green A, Bunk D, Rudnick P, Kilpatrick L, Phinney K. A proteomics performance standard to support measurement quality in proteomics. Proteomics. 2012;12(7):923-931. doi: 10.1002/pmic.201100522 [DOI] [PubMed] [Google Scholar]
- 46.Gygi JP, Ramin R, Navarrete-Perea J, Younesi S, Gygi SP, Paulo JA. A triple knockout isobaric-labeling quality control platform with an integrated online database search. J Am Soc Mass Spectrom. 2020;31(7):1344-1349. doi: 10.1021/jasms.0c00029 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Navarro P, Kuharev J, Gillet LC, et al. A multicenter study benchmarks software tools for label-free proteome quantification. Nat Biotechnol. 2016;34(11):1130-1136. doi: 10.1038/nbt.3685 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Kockmann T, Trachsel C, Panse C, et al. Targeted proteomics coming of age - SRM, PRM and DIA performance evaluated from a core facility perspective. Proteomics. 2016;16(15-16):2183-2192. doi: 10.1002/pmic.201500502 [DOI] [PubMed] [Google Scholar]
- 49.Srzentic K, Fornelli L, Tsybin YO, et al. Interlaboratory study for characterizing monoclonal antibodies by top-down and middle-down mass spectrometry. J Am Soc Mass Spectrom. 2020;31(9):1783-1802. doi: 10.1021/jasms.0c00036 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.De Leoz MLA, Duewer DL, Stein SE. NIST interlaboratory study on the glycosylation of NISTmAb, a monoclonal antibody reference material June 2015 to February 2016. NIST Interagency/Internal Report no. 8186. Published July 31, 2017. doi: 10.6028/NIST.IR.8186 [DOI] [Google Scholar]
- 51.Van Den Bossche T, Kunath BJ, Schallert K, et al. Critical assessment of MetaProteome Investigation (CAMPI): a multi-laboratory comparison of established workflows. Nature Commun. 2021;12(1):7305. doi: 10.1038/s41467-021-27542-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Beri J, Rosenblatt MM, Strauss E, Urh M, Bereman MS. Reagent for evaluating liquid chromatographytandem mass spectrometry (LC-MS/MS) performance in bottom-up proteomic experiments. Anal Chem. 2015;87(23):11635-11640. doi: 10.1021/acs.analchem.5b04121 [DOI] [PubMed] [Google Scholar]
- 53.Koskinen VR, Emery PA, Creasy DM, Cottrell JS. Hierarchical clustering of shotgun proteomics data. Mol Cell Proteomics. 2011;10(6):M110.003822. doi: 10.1074/mcp.M110.003822 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Kwon T, Choi H, Vogel C, Nesvizhskii AI, Marcotte EM. MSblender: a probabilistic approach for integrating peptide identifications from multiple database search engines. J Proteome Res. 2011;10(7):2949-2958. doi: 10.1021/pr2002116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Chen YY, Dasari S, Ma ZQ, Vega-Montoto LJ, Li M, Tabb DL. Refining comparative proteomics by spectral counting to account for shared peptides and multiple search engines. Anal Bioanal Chem. 2012;404(4):1115-1125. doi: 10.1007/s00216-012-6011-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Ghali F, Krishna R, Lukasse P, et al. Tools (Viewer, Library and Validator) that facilitate use of the peptide and protein identification standard format, termed mzIdentML. Mol Cell Proteomics. 2013;12(11):3026-3035. doi: 10.1074/mcp.O113.029777 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Degroeve S, Martens L. MS2PIP: a tool for MS/MS peak intensity prediction. Bioinformatics. 2013;29(24):3199-3203. doi: 10.1093/bioinformatics/btt544 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Fu Y, Qian X. Transferred subgroup false discovery rate for rare post-translational modifications detected by mass spectrometry. Mol Cell Proteomics. 2014;13(5):1359-1368. doi: 10.1074/mcp.O113.030189 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Granholm V, Kim S, Navarro JC, Sjölund E, Smith RD, Käll L. Fast and accurate database searches with MS-GF+Percolator. J Proteome Res. 2014;13(2):890-897. doi: 10.1021/pr400937n [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Seymour SL, Farrah T, Binz PA, et al. A standardized framing for reporting protein identifications in mzIdentML 1.2. Proteomics. 2014;14(21-22):2389-2399. doi: 10.1002/pmic.201400080 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Zhang B, Käll L, Zubarev RA. DeMix-Q: quantification-centered data processing workflow. Mol Cell Proteomics. 2016;15(4):1467-1478. doi: 10.1074/mcp.O115.055475 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Zhang B, Pirmoradian M, Zubarev R, Käll L. Covariation of peptide abundances accurately reflects protein concentration differences. Mol Cell Proteomics. 2017;16(5):936-948. doi: 10.1074/mcp.O117.067728 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 63.Shen X, Shen S, Li J, et al. IonStar enables high-precision, low-missing-data proteomics quantification in large biological cohorts. Proc Natl Acad Sci U S A. 2018;115(21):E4767-e4776. doi: 10.1073/pnas.1800541115 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Palmblad M, Lamprecht AL, Ison J, Schwämmle V. Automated workflow composition in mass spectrometry-based proteomics. Bioinformatics. 2019;35(4):656-664. doi: 10.1093/bioinformatics/bty646 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65.Wen B, Wang X, Zhang B. PepQuery enables fast, accurate, and convenient proteomic validation of novel genomic alterations. Genome Res. 2019;29(3):485-493. doi: 10.1101/gr.235028.118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Griss J, Stanek F, Hudecz O, et al. Spectral clustering improves label-free quantification of low-abundant proteins. J Proteome Res. 2019;18(4):1477-1485. doi: 10.1021/acs.jproteome.8b00377 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Chen AT, Franks A, Slavov N. DART-ID increases single-cell proteome coverage. PLoS Comput Biol. 2019;15(7):e1007082. doi: 10.1371/journal.pcbi.1007082 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Bittremieux W, Laukens K, Noble WS. Extremely fast and accurate open modification spectral library searching of high-resolution mass spectra using feature hashing and graphics processing units. J Proteome Res. 2019;18(10):3792-3799. doi: 10.1021/acs.jproteome.9b00291 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Hulstaert N, Shofstahl J, Sachsenberg T, et al. ThermoRawFileParser: modular, scalable, and crossplatform RAW file conversion. J Proteome Res. 2020;19(1):537-542. doi: 10.1021/acs.jproteome.9b00328 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Pfeuffer J, Sachsenberg T, Dijkstra TMH, Serang O, Reinert K, Kohlbacher O. EPIFANY: a method for efficient high-confidence protein inference. J Proteome Res. 2020;19(3):1060-1072. doi: 10.1021/acs.jproteome.9b00566 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Tsai TH, Choi M, Banfai B, et al. Selection of features with consistent profiles improves relative protein quantification in mass spectrometry experiments. Mol Cell Proteomics. 2020;19(6):944-959. doi: 10.1074/mcp.RA119.001792 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Dermit M, Peters-Clarke TM, Shishkova E, Meyer JG. Peptide correlation analysis (PeCorA) reveals differential Proteoform regulation. J Proteome Res. 2021;20(4):1972-1980. doi: 10.1021/acs.jproteome.0c00602 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Ivanov MV, Solovyeva EM, Bubis JA, Gorshkov MV. Improving the protein inference from bottom-up proteomic data using identifications from MS1 spectra. J Am Soc Mass Spectrom. 2021;32(5):1258-1262. doi: 10.1021/jasms.1c00061 [DOI] [PubMed] [Google Scholar]
- 74.Kalxdorf M, Müller T, Stegle O, Krijgsveld J. IceR improves proteome coverage and data completeness in global and single-cell proteomics. Nat Commun. 2021;12(1):4787. doi: 10.1038/s41467-021-25077-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.O'Connell JD, Paulo JA, O'Brien JJ, Gygi SP. Proteome-wide evaluation of two common protein quantification methods. J Proteome Res. 2018;17(5):1934-1942. doi: 10.1021/acs.jproteome.8b00016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Mappa C, Alpha-Bazin B, Pible O, Armengaud J. Mix24X, a lab-assembled reference to evaluate interpretation procedures for tandem mass spectrometry proteotyping of complex samples. Int J Mol Sci. 2023;24(10). doi: 10.3390/ijms24108634 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Jagtap PD, Hoopmann MR, Neely BA, et al. The Association of Biomolecular Resource Facilities Proteome Informatics Research Group Study on Metaproteomics (iPRG-2020). J Biomol Tech. 2023;34(3). doi: 10.7171/3fc1f5fe.a058bad4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Burger B, Vaudel M, Barsnes H. Importance of block randomization when designing proteomics experiments. J Proteome Res. 2021;20(1):122-128. doi: 10.1021/acs.jproteome.0c00536 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.St John-Williams L, Blach C, Toledo JB, et al. Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. Sci Data. 2017;4:170140. doi: 10.1038/sdata.2017.140 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 80.Tsantilas KA, Merrihew GE, Robbins JE, et al. A framework for quality control in quantitative proteomics. bioRxiv. 2024. doi: 10.1101/2024.04.12.589318 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Oliver NC, Choi MJ, Arul AB, Whitaker MD, Robinson RAS. Establishing quality control metrics for large-scale plasma proteomic sample preparation. ACS Meas Sci Au. 2024;4(4):442-451. doi: 10.1021/acsmeasuresciau.3c00070 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Maxwell CB, Sandhu JK, Cao TH, McCann GP, Ng LL, Jones DJL. The edge effect in high-throughput proteomics: a cautionary tale. J Am Soc Mass Spectrom. 2023;34(6):1065-1072. doi: 10.1021/jasms.3c00035 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Marissen R, Varunjikar MS, Laros JFJ, Rasinger JD, Neely BA, Palmblad M. compareMS2 2.0: an improved software for comparing tandem mass spectrometry datasets. J Proteome Res. 2023;22(2):514-519. doi: 10.1021/acs.jproteome.2c00457 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.van der Plas-Duivesteijn SJ, Wulff T, Klychnikov O, et al. Differentiating samples and experimental protocols by direct comparison of tandem mass spectra. Rapid Commun Mass Spectrom. 2016;30(6):731-738. doi: 10.1002/rcm.7494 [DOI] [PubMed] [Google Scholar]
- 85.Paulovich AG, Billheimer D, Ham AJ, et al. Interlaboratory study characterizing a yeast performance standard for benchmarking LC-MS platform performance. Mol Cell Proteomics. 2010;9(2):242-254. doi: 10.1074/mcp.M900222-MCP200 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Ma ZQ, Polzin KO, Dasari S, et al. QuaMeter: multivendor performance metrics for LC-MS/MS proteomics instrumentation. Anal Chem. 2012;84(14):5845-5850. doi: 10.1021/ac300629p [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Pichler P, Mazanek M, Dusberger F, et al. SIMPATIQCO: a server-based software suite which facilitates monitoring the time course of LC-MS performance metrics on Orbitrap instruments. J Proteome Res. 2012;11(11):5540-5547. doi: 10.1021/pr300163u [DOI] [PMC free article] [PubMed] [Google Scholar]
- 88.Burkhart JM, Premsler T, Sickmann A. Quality control of nano-LC-MS systems using stable isotopecoded peptides. Proteomics. 2011;11(6):1049-1057. doi: 10.1002/pmic.201000604 [DOI] [PubMed] [Google Scholar]
- 89.Bowser BL, Patterson KL, Robinson RA. Evaluating cPILOT data toward quality control implementation. J Am Soc Mass Spectrom. 2023;34(8):1741-1752. doi: 10.1021/jasms.3c00179 [DOI] [PubMed] [Google Scholar]
- 90.Jenkins C, Orsburn BC. Simple tool for rapidly assessing the quality of multiplexed single cell proteomics data. J Am Soc Mass Spectrom. 2023;34(12):2615-2619. doi: 10.1021/jasms.3c00238 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Keller BO, Sui J, Young AB, Whittal RM. Interferences and contaminants encountered in modern mass spectrometry. Anal Chim Acta. 2008;627(1):71-81. doi: 10.1016/j.aca.2008.04.043 [DOI] [PubMed] [Google Scholar]
- 92.Rardin MJ. Rapid assessment of contaminants and interferences in mass spectrometry data using Skyline. J Am Soc Mass Spectrom. 2018;29(6):1327-1330. doi: 10.1007/s13361-018-1940-z [DOI] [PubMed] [Google Scholar]
- 93.Gomez-Zepeda D, Michna T, Ziesmann T, Distler U, Tenzer S. HowDirty: an R package to evaluate molecular contaminants in LC-MS experiments. Proteomics. 2024;24(8):e2300134. doi: 10.1002/pmic.202300134 [DOI] [PubMed] [Google Scholar]
- 94.Geyer PE, Voytik E, Treit PV, et al. Plasma proteome profiling to detect and avoid sample-related biases in biomarker studies. EMBO Mol Med. 2019;11(11):e10427. doi: 10.15252/emmm.201910427 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Barker M, Chue Hong NP, Katz DS, et al. Introducing the FAIR principles for research software. Sci Data. 2022;9(1):622. doi: 10.1038/s41597-022-01710-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Gygi JP, Yu Q, Navarrete-Perea J, Rad R, Gygi SP, Paulo JA. Web-based search tool for visualizing instrument performance using the triple knockout (TKO) proteome standard. J Proteome Res. 2019;18(2):687-693. doi: 10.1021/acs.jproteome.8b00737. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Dai C, Pfeuffer J, Wang H, et al. quantms: a cloud-based pipeline for proteomics reanalysis enables the quantification of 17521 proteins in 9,502 human samples. Res Sq. 2023. doi: 10.21203/rs.3.rs-3002027/v1 [DOI] [Google Scholar]
- 98.Ewels P, Magnusson M, Lundin S, Käller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047-3048. doi: 10.1093/bioinformatics/btw354 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 99.Pfeuffer J, Bielow C, Wein S, et al. OpenMS 3 enables reproducible analysis of large-scale mass spectrometry data. Nat Methods. 2024;21(3):365-367. doi: 10.1038/s41592-024-02197-7 [DOI] [PubMed] [Google Scholar]
- 100.Rozanova S, Uszkoreit J, Schork K, et al. Quality control-a stepchild in quantitative proteomics: a case study for the Human CSF Proteome. Biomolecules. 2023;13(3). doi: 10.3390/biom13030491 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Dogu E, Taheri SM, Olivella R, et al. MSstatsQC 2.0: R/Bioconductor package for statistical quality control of mass spectrometry-based proteomics experiments. J Proteome Res. 2019;18(2):678-686. doi: 10.1021/acs.jproteome.8b00732 [DOI] [PubMed] [Google Scholar]
- 102.Dogu E, Mohammad-Taheri S, Abbatiello SE, et al. MSstatsQC: longitudinal system suitability monitoring and quality control for targeted proteomic experiments. Mol Cell Proteomics. 2017;16(7):1335-1347. doi: 10.1074/mcp.M116.064774 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Degnan DJ, Stratton KG, Richardson R, et al. pmartR 2.0: a quality control, visualization, and statistics pipeline for multiple omics datatypes. J Proteome Res. 2023;22(2):570-576. doi: 10.1021/acs.jproteome.2c00610 [DOI] [PubMed] [Google Scholar]
- 104.Stratton KG, Webb-Robertson BM, McCue LA, et al. pmartR: quality control and statistics for mass spectrometry-based biological data. J Proteome Res. 2019;18(3):1418-1425. doi: 10.1021/acs.jproteome.8b00760 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Riffle M, Jaschob D, Zelter A, Davis TN. ProXL (Protein Cross-Linking Database): a platform for analysis, visualization, and sharing of protein cross-linking mass spectrometry data. J Proteome Res. 2016;15(8):2863-2870. doi: 10.1021/acs.jproteome.6b00274 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Bielow C, Mastrobuoni G, Kempa S. Proteomics quality control: quality control software for MaxQuant results. J Proteome Res. 2016;15(3):777-787. doi: 10.1021/acs.jproteome.5b00780 [DOI] [PubMed] [Google Scholar]
- 107.Stanfill BA, Nakayasu ES, Bramer LM, et al. Quality Control Analysis in Real-Time (QC-ART): a tool for real-time quality control assessment of mass spectrometry-based proteomics data. Mol Cell Proteomics. 2018;17(9):1824-1836. doi: 10.1074/mcp.RA118.000648 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Olivella R, Chiva C, Serret M, et al. QCloud2: an improved cloud-based quality-control system for mass-spectrometry-based proteomics laboratories. J Proteome Res. 2021;20(4):2010-2013. doi: 10.1021/acs.jproteome.0c00853 [DOI] [PubMed] [Google Scholar]
- 109.Chiva C, Olivella R, Borràs E, et al. QCloud: a cloud-based quality control system for mass spectrometry-based proteomics laboratories. PLoS One. 2018;13(1):e0189209. doi: 10.1371/journal.pone.0189209 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Sandhu W, Gray IJ, Lin S, Elias JE, DeFelice BC. Rapid QC-MS – interactive dashboard for synchronous mass spectrometry data acquisition quality control. bioRxiv. 2024. doi: 10.1101/2024.01.30.578059 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Morgenstern D, Barzilay R, Levin Y. RawBeans: a simple, vendor-independent, raw-data qualitycontrol tool. J Proteome Res. 2021;20(4):2098-2104. doi: 10.1021/acs.jproteome.0c00956 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 112.Dong Y, Kazachkova Y, Gou M, et al. RawHummus: an R Shiny app for automated raw data quality control in metabolomics. Bioinformatics. 2022;38(7):2072-2074. doi: 10.1093/bioinformatics/btac040 [DOI] [PubMed] [Google Scholar]
- 113.Navarrete-Perea J, Liu X, Rad R, Gygi JP, Gygi SP, Paulo JA. Assessing interference in isobaric tagbased sample multiplexing using an 18-plex interference standard. Proteomics. 2022;22(7):e2100317. doi: 10.1002/pmic.202100317 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Bielow C, Hoffmann N, Jimenez-Morales D, et al. Communicating mass spectrometry quality information in mzQC with Python, R, and Java. J Am Soc Mass Spectrom. 2024;35(8)1875-1882. doi: 10.1021/jasms.4c00174 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Neely BA, Dorfer V, Martens L, et al. Toward an integrated machine learning model of a proteomics experiment. J Proteome Res. 2023;22(3):681-696. doi: 10.1021/acs.jproteome.2c00711 [DOI] [PMC free article] [PubMed] [Google Scholar]
